Ellis CN - Search Results

1

Repeat courses of intravenous alefacept in patients with chronic plaque psoriasis provide consistent safety and efficacy.

Lowe NJ, Gonzalez J, Bagel J, Caro I, Ellis CN, Menter A. Lowe NJ, et al. Among authors: ellis cn. Int J Dermatol. 2003 Mar;42(3):224-30. doi: 10.1046/j.1365-4362.2003.01793.x. Int J Dermatol. 2003. PMID: 12653922 Free article. Clinical Trial.

2

The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study.

Stern RS, Fitzgerald E, Ellis CN, Lowe N, Goldfarb MT, Baughman RD. Stern RS, et al. Among authors: ellis cn. J Am Acad Dermatol. 1995 Jul;33(1):44-52. doi: 10.1016/0190-9622(95)90008-x. J Am Acad Dermatol. 1995. PMID: 7601945 Clinical Trial.

3

A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatoses.

Guzzo CA, Weiss JS, Mogavero HS, Ellis CN, Zaias N, Lowe NJ, Kerdel FA, Milbauer JJ, Bernhard JD, Whitmore C, et al. Guzzo CA, et al. Among authors: ellis cn. J Am Acad Dermatol. 1991 Dec;25(6 Pt 2):1179-83. doi: 10.1016/0190-9622(91)70322-s. J Am Acad Dermatol. 1991. PMID: 1757614 Free article. Clinical Trial.

4

Efficacy of a 1-week, twice-daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. Results of placebo-controlled, double-blind, multicenter trials.

Berman B, Ellis C, Leyden J, Lowe N, Savin R, Shupack J, Stiller M, Tschen E, Zaias N, Birnbaum JE. Berman B, et al. J Am Acad Dermatol. 1992 Jun;26(6):956-60. doi: 10.1016/0190-9622(92)70141-2. J Am Acad Dermatol. 1992. PMID: 1607415 Clinical Trial.

5

Alefacept therapy produces remission for patients with chronic plaque psoriasis.

Krueger GG, Ellis CN. Krueger GG, et al. Among authors: ellis cn. Br J Dermatol. 2003 Apr;148(4):784-8. doi: 10.1046/j.1365-2133.2003.05239.x. Br J Dermatol. 2003. PMID: 12752139 Free article. Clinical Trial.

6

A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis.

Krueger GG, Papp KA, Stough DB, Loven KH, Gulliver WP, Ellis CN; Alefacept Clinical Study Group. Krueger GG, et al. Among authors: ellis cn. J Am Acad Dermatol. 2002 Dec;47(6):821-33. doi: 10.1067/mjd.2002.127247. J Am Acad Dermatol. 2002. PMID: 12451365 Clinical Trial.

7

Effects of alefacept on health-related quality of life in patients with psoriasis: results from a randomized, placebo-controlled phase II trial.

Ellis CN, Mordin MM, Adler EY; Randomized, placebo-controlled phase II trial. Ellis CN, et al. Am J Clin Dermatol. 2003;4(2):131-9. doi: 10.2165/00128071-200304020-00005. Am J Clin Dermatol. 2003. PMID: 12553852 Clinical Trial.

8

Suicidal ideation in psoriasis.

Gupta MA, Schork NJ, Gupta AK, Kirkby S, Ellis CN. Gupta MA, et al. Among authors: ellis cn. Int J Dermatol. 1993 Mar;32(3):188-90. doi: 10.1111/j.1365-4362.1993.tb02790.x. Int J Dermatol. 1993. PMID: 8444530 Free article.

9

Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.

Ellis CN, Krueger GG; Alefacept Clinical Study Group. Ellis CN, et al. N Engl J Med. 2001 Jul 26;345(4):248-55. doi: 10.1056/NEJM200107263450403. N Engl J Med. 2001. PMID: 11474662 Free article. Clinical Trial.

10

Intralesional cyclosporine for psoriasis. Relationship of dose, tissue levels, and efficacy.

Burns MK, Ellis CN, Eisen D, Duell E, Griffiths CE, Annesley TM, Hamilton TA, Birnbaum JE, Voorhees JJ. Burns MK, et al. Among authors: ellis cn. Arch Dermatol. 1992 Jun;128(6):786-90. doi: 10.1001/archderm.128.6.786. Arch Dermatol. 1992. PMID: 1599264 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters